Molecular mechanisms and physiological functions of mitophagy

M Onishi, K Yamano, M Sato, N Matsuda… - The EMBO …, 2021 - embopress.org
Degradation of mitochondria via a selective form of autophagy, named mitophagy, is a
fundamental mechanism conserved from yeast to humans that regulates mitochondrial …

Mitophagy in human diseases

L Doblado, C Lueck, C Rey, AK Samhan-Arias… - International journal of …, 2021 - mdpi.com
Mitophagy is a selective autophagic process, essential for cellular homeostasis, that
eliminates dysfunctional mitochondria. Activated by inner membrane depolarization, it plays …

Mitochondrial stasis reveals p62-mediated ubiquitination in parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease

T Yamada, D Murata, Y Adachi, K Itoh, S Kameoka… - Cell metabolism, 2018 - cell.com
It is unknown what occurs if both mitochondrial division and fusion are completely blocked.
Here, we introduced mitochondrial stasis by deleting two dynamin-related GTPases for …

Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression

N Nimer, I Choucair, Z Wang, I Nemet, L Li, J Gukasyan… - Metabolism, 2021 - Elsevier
Objective Metabolomic studies suggest plasma levels of bile acids (BAs) are elevated
amongst subjects with non-alcoholic fatty liver disease (NAFLD) compared to healthy …

Altered bile acid metabolome in patients with nonalcoholic steatohepatitis

BC Ferslew, G Xie, CK Johnston, M Su… - Digestive diseases and …, 2015 - Springer
Abstract Background and Aims The prevalence of nonalcoholic fatty liver disease (NAFLD)
and steatohepatitis (NASH) is increasing at an alarming rate. The role of bile acids in the …

Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities

F Idalsoaga, AV Kulkarni, OY Mousa, M Arrese… - Frontiers in …, 2020 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide, with a prevalence of 25–30%. Since its first description in 1980, NAFLD has …

[HTML][HTML] Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity

J Massart, K Begriche, C Moreau… - Journal of clinical and …, 2017 - ncbi.nlm.nih.gov
Background: Obesity is often associated with nonalcoholic fatty liver disease (NAFLD),
which refers to a large spectrum of hepatic lesions including fatty liver, nonalcoholic …

[HTML][HTML] Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation

J Yuan, Z Yu, J Gao, K Luo, X Shen, B Cui, Z Lu - Redox biology, 2022 - Elsevier
The development of nonalcoholic fatty liver disease (NAFLD) is associated with increased
reactive oxygen species (ROS) production. Previous observations on the contradictory roles …

Biomolecules and biomarkers used in diagnosis of alcohol drinking and in monitoring therapeutic interventions

RM Nanau, MG Neuman - Biomolecules, 2015 - mdpi.com
Background: The quantitative, measurable detection of drinking is important for the
successful treatment of alcohol misuse in transplantation of patients with alcohol disorders …

Alcoholic liver disease: current mechanistic aspects with focus on their clinical relevance

R Teschke - Biomedicines, 2019 - mdpi.com
The spectrum of alcoholic liver disease (ALD) is broad and includes alcoholic fatty liver,
alcoholic steatohepatitis, alcoholic hepatitis, alcoholic fibrosis, alcoholic cirrhosis, and …